← Back to Search

Topical Cream

EVO101 Cream for Atopic Dermatitis

Phase 2

Waitlist Available

Research Sponsored by Evommune, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial will test a new drug to treat atopic dermatitis in adults to see if it's safe & effective.

Eligible Conditions

Atopic Dermatitis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Eczema Area and Severity Index (EASI)

Secondary outcome measures

Body Surface Area (BSA)

Investigator Global Assessment (IGA)

Pruritus-NRS

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: EVO101 CreamExperimental Treatment1 Intervention

Active Treatment, BID, 8 weeks

Group II: Vehicle CreamPlacebo Group1 Intervention

Vehicle Treatment, BID, 8 weeks

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EVO101

2022

Completed Phase 2

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Evommune, Inc.Lead Sponsor

Eugene Bauer, MDStudy DirectorEvommune, Inc.

3 Previous Clinical Trials

488 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do numerous hospitals in Canada support this research?

"Dermatology Research Associates, Centre for Clinical Studies, Ltd LLC, and Minnesota Clinical Study Centre are the lead institutions running this trial, with support from 15 other locations."

Answered by AI

Are there any possible side effects to using EVO101 Cream?

"Since this is a Phase 2 trial, EVO101 Cream received a score of 2. This is because while there is some data supporting the cream's safety, there is no data supporting its efficacy."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

2022. "Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05579899.